Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glycogen Metabolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02432768
What this trial is testing

The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V)

Who this might be right for
Glycogen Storage Disease Type V
Rigshospitalet, Denmark 22
Not applicableStudy completedNCT04678713
What this trial is testing

Maximal Fat Oxidation and Fuel Use During Exercise

Who this might be right for
Obesity
University of Copenhagen 40
Testing effectiveness (Phase 2)Study completedNCT02824003
What this trial is testing

Study to Evaluate the Effect of ISIS GCGRRx on Hepatic Lipid and Glycogen Content in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Ionis Pharmaceuticals, Inc. 15
Not applicableStudy completedNCT02765828
What this trial is testing

Identification of Tongue Involvement in Late-Onset Pompe Disease

Who this might be right for
MyopathyNeuropathyGlycogen Storage Disease Type II (Late-onset Pompe Disease)
Duke University 73
Not applicableUnknownNCT03211923
What this trial is testing

Muscle Relaxation in Myopathies With Positive Muscle Phenomena

Who this might be right for
Nemaline Myopathy Type 6Myotonic Dystrophy Type 2McArdle Disease
Radboud University Medical Center 30
Post-approval studies (Phase 4)Looking for participantsNCT06666413
What this trial is testing

China Post-approval Commitment (PAC) Study of Avalglucosidase Alfa in Participants With IOPD

Who this might be right for
Glycogen Storage Disease Type IIPompe's Disease
Genzyme, a Sanofi Company 13
Not applicableLooking for participantsNCT03564561
What this trial is testing

Natural History of Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II, Adult
Assistance Publique - Hôpitaux de Paris 20
Testing effectiveness (Phase 2)UnknownNCT03404856
What this trial is testing

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

Who this might be right for
Glycogen Storage Disease, Type 14
Orpha Labs 5
Post-approval studies (Phase 4)Study completedNCT04676373
What this trial is testing

Study to Evaluate Efficacy and Safety in Chinese Patients With Late Onset Pompe Disease With Alglucosidase Alfa Treatmen

Who this might be right for
Pompe's Disease
Genzyme, a Sanofi Company 41
Testing effectiveness (Phase 2)UnknownNCT04138251
What this trial is testing

Safety, Efficacy Evaluation of Empagliflozin Administration for Neutropenia in Glycogenosis Type 1b and G6PC3 Deficiency

Who this might be right for
Glycogen Storage Disease Type IGlucose 6 Phosphatase Deficiency
Cliniques universitaires Saint-Luc- Université Catholique de Louvain 5
Early research (Phase 1)Looking for participantsNCT07354724
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease

Who this might be right for
Late-onset Pompe Disease
Denali Therapeutics Inc. 32
Early research (Phase 1)Study completedNCT05078879
What this trial is testing

Empagliflozin as a Treatment for Severe Congenital Neutropenia Due to G6PC3 Deficiency

Who this might be right for
Crohn's DiseaseGlycogen MetabolismInflammatory Bowel Disease (IBD)
National Institute of Allergy and Infectious Diseases (NIAID) 4
Not applicableUnknownNCT03045042
What this trial is testing

Search for Serum/Plasma Biomarkers in Pompe's Disease

Who this might be right for
Late Onset Pompe DiseasePompe Disease
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 35
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Not applicableUnknownNCT04004676
What this trial is testing

Ketone Supplementation, Glycogen Replenishment and Time Trial Performance Following Glycogen Lowering Exercise

Who this might be right for
KetonemiaExercise PerformanceKetosis
Western University, Canada 20
Not applicableStudy completedNCT00731081
What this trial is testing

Study About the Evolution of Severe Late Onset Pompe Disease Patient With Pulmonary Dysfunction and Receiving Myozyme®

Who this might be right for
Pompe Disease (Late-Onset)Glycogen Storage Disease Type II (GSD II)Glycogenesis 2 Acid Maltase Deficiency
Genzyme, a Sanofi Company 8
Not applicableStudy completedNCT00077662
What this trial is testing

A Prospective, Observational Study in Patients With Late-Onset Pompe Disease

Who this might be right for
Glycogen Storage Disease Type II
Genzyme, a Sanofi Company 61
Not applicableLooking for participantsNCT04200391
What this trial is testing

Very Low Carbohydrate Diets and Glucagon Response in T1DM

Who this might be right for
Type1diabetes
Boston Children's Hospital 12
Not applicableActive Not RecruitingNCT03694561
What this trial is testing

Developing a Management Approach for Patients With "Late-Onset" Pompe Disease

Who this might be right for
Pompe DiseasePompe Disease (Late-onset)GAA Deficiency
Duke University 20
Testing effectiveness (Phase 2)Ended earlyNCT00688597
What this trial is testing

Study to Evaluate the Safety of AT2220 (Duvoglustat) in Pompe Disease

Who this might be right for
Pompe Disease
Amicus Therapeutics 3
Next Page